Nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series. Read more about Nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series.
Influence of African American race on the association between preoperative biopsy grade group and adverse histopathologic features of radical prostatectomy. Read more about Influence of African American race on the association between preoperative biopsy grade group and adverse histopathologic features of radical prostatectomy.
Poorly controlled diabetes increases the risk of metastases and castration-resistant prostate cancer in men undergoing radical prostatectomy: Results from the SEARCH database. Read more about Poorly controlled diabetes increases the risk of metastases and castration-resistant prostate cancer in men undergoing radical prostatectomy: Results from the SEARCH database.
Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials. Read more about Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials.
Differential use of medical versus surgical androgen deprivation therapy for patients with metastatic prostate cancer. Read more about Differential use of medical versus surgical androgen deprivation therapy for patients with metastatic prostate cancer.
Does race predict the development of metastases in men who receive androgen-deprivation therapy for a biochemical recurrence after radical prostatectomy? Read more about Does race predict the development of metastases in men who receive androgen-deprivation therapy for a biochemical recurrence after radical prostatectomy?
Clinical trials involving carbon-ion radiation therapy and the path forward. Read more about Clinical trials involving carbon-ion radiation therapy and the path forward.
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials. Read more about Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials.
Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives. Read more about Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives.
Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention. Read more about Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention.
